Shustov Andrei 4
4 · Cellectar Biosciences, Inc. · Filed Mar 16, 2023
Insider Transaction Report
Form 4
Shustov Andrei
Senior Vice President, Medical
Transactions
- Award
Stock option (right to buy)
2023-02-15+100,000→ 100,000 totalExercise: $1.67Exp: 2033-02-15→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]This option shall vest in three approximately equal annual installments beginning on the first anniversary of the date of grant, subject to the Reporting Person's continuous employment by the Issuer on each vesting date.